Schott Pharma Logo

Schott Pharma

1SXP | F

Overview

Corporate Details

ISIN(s):
DE000A3ENQ51
LEI:
529900TU48UE99NHEY88
Country:
Germany
Address:
Hattenbergstraße 10, 55122 Mainz
Sector:
Health Care
Industry:
Pharmaceuticals

Description

Schott Pharma is a leading pharmaceutical company dedicated to improving the quality of life through the development and production of innovative healthcare solutions. With a rich history dating back over a century, Schott Pharma has established itself as a trusted name in the industry, known for its commitment to excellence and unwavering focus on patient care. At Schott Pharma, our mission is to provide safe, effective, and accessible medications that address the evolving needs of patients worldwide. We believe in the power of research and collaboration, working closely with healthcare professionals, scientists, and regulatory authorities to develop breakthrough therapies that make a difference. Our state-of-the-art facilities are equipped with advanced technologies and adhere to the highest quality standards, ensuring that every product we manufacture meets stringent regulatory requirements. From pharmaceutical packaging solutions to drug delivery systems.

Social Media

Market Data

Market Data Not Available

Financials & KPIs

No data available

No Financial Data Available

Standardized financial statements for the selected period are not yet available.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Date Filing Language Size Actions
2025-06-11 08:50
Board/Management Change
SCHOTT Pharma Supervisory Board extends contract of CEO Andreas Reisse and appo…
English 12.3 KB
2025-06-04 15:30
Regulatory News Service
SCHOTT Pharma invests in sterile cartridge production in Hungary
English 8.9 KB
2025-05-16 00:00
Regulatory News Service
Half-yearly financial report 2024/2025
English 885.8 KB
2025-05-15 07:00
Earnings Release
SCHOTT Pharma delivers strong second quarter of fiscal year 2025
English 33.6 KB
2025-05-15 00:00
Regulatory News Service
Presentation H1 2025
English 672.0 KB
2025-05-06 07:00
Regulatory News Service
SCHOTT Pharma and Serum Institute of India welcome new partner to Joint Venture…
English 15.0 KB
2025-04-11 18:15
Regulatory News Service
SCHOTT Pharma AG & Co. KGaA: SCHOTT Pharma: Preliminary Q2 2025 figures exceed …
English 5.4 KB
2025-04-10 15:58
Regulatory News Service
Next expansion milestone achieved: SCHOTT Pharma opens production facility in S…
English 9.6 KB
2025-04-02 16:00
Regulatory News Service
English 4.8 KB
2025-02-14 07:00
Earnings Release
SCHOTT Pharma records good start into fiscal year and confirms full year outlook
English 23.5 KB
2025-02-13 07:00
Earnings Release
SCHOTT Pharma records good start into fiscal year and confirms full year outlook
English 23.5 KB
2025-02-13 00:00
Regulatory News Service
Presentation Q1 2025
English 893.1 KB
2025-02-13 00:00
Quarterly Report
Q1 statement / Q1 financial report 2024/2025
English 693.2 KB
2025-02-04 18:22
Regulatory News Service
SCHOTT Pharma with successful Annual General Meeting: Shareholders approve all …
English 14.5 KB
2025-01-14 13:55
Declaration of Voting Results & Voting Rights Announcements
English 14.0 KB

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Company Country Ticker View
AstraZeneca PLC Logo AstraZeneca PLC United Kingdom AZN
Basilea Pharmaceutica AG Logo Basilea Pharmaceutica AG Switzerland BSLN
Bayer AG Logo Bayer AG Germany BAY
Biogened Spolka Akcyjna Logo Biogened Spolka Akcyjna Poland BGD
Biotika A.S. Logo Biotika A.S. Slovakia BSL
Bio Vitos Pharma AB Logo Bio Vitos Pharma AB Sweden BIOVIT
BOIRON Logo BOIRON France BOI
Bonyf N.V. Logo Bonyf N.V. Belgium MLBON
Bosnalijek d.d. Sarajevo Logo Bosnalijek d.d. Sarajevo Bosnia and Herzegovina BSNL
Calliditas Therapeutics Logo Calliditas Therapeutics Sweden CALTX